Correction to: Oncogenesis (2016) 5, e224; doi:10.1038/oncsis.2016.35; published online 9 May 2016
Since the publication of the above article, the authors have realized that both Figure 2c, apoptosis figure of Agomir-186-NC group of SGC7901 cell, and Figure 4c, apoptosis figure of Antagomir-186+shHIF-1α, were wrongly used.
Figure 2
Figure 4
The corrected figures are shown here.
The authors would like to apologize to the readers for any inconvenience this may have caused.
Additional information
The online version of the original article can be found at 10.1038/oncsis.2016.35
Rights and permissions
Oncogenesis is an open-access journal published by Nature Publishing Group. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Liu, L., Wang, Y., Bai, R. et al. Erratum: MiR-186 inhibited aerobic glycolysis in gastric cancer via HIF-1α regulation. Oncogenesis 6, e318 (2017). https://doi.org/10.1038/oncsis.2017.20
Published:
Issue Date:
DOI: https://doi.org/10.1038/oncsis.2017.20
This article is cited by
-
FSCN1 promotes proliferation, invasion and glycolysis via the IRF4/AKT signaling pathway in oral squamous cell carcinoma
BMC Oral Health (2023)
-
RETRACTED ARTICLE: MicroRNA-4268 inhibits cell proliferation via AKT/JNK signalling pathways by targeting Rab6B in human gastric cancer
Cancer Gene Therapy (2020)
-
MicroRNA-1269 promotes cell proliferation via the AKT signaling pathway by targeting RASSF9 in human gastric cancer
Cancer Cell International (2019)
-
miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1
Oncogene (2018)
